Genomic Medicine Program Advisory Committee; Notice of Renewal, 11467-11468 [08-910]
Download as PDF
rmajette on PROD1PC64 with NOTICES
Federal Register / Vol. 73, No. 42 / Monday, March 3, 2008 / Notices
admission into the United States unless
NHTSA has decided that the motor
vehicle is substantially similar to a
motor vehicle originally manufactured
for importation into and sale in the
United States, certified under 49 U.S.C.
30115, and of the same model year as
the model of the motor vehicle to be
compared, and is capable of being
readily altered to conform to all
applicable FMVSS.
Petitions for eligibility decisions may
be submitted by either manufacturers or
importers who have registered with
NHTSA pursuant to 49 CFR Part 592. As
specified in 49 CFR 593.7, NHTSA
publishes notice in the Federal Register
of each petition that it receives, and
affords interested persons an
opportunity to comment on the petition.
At the close of the comment period,
NHTSA decides, on the basis of the
petition and any comments that it has
received, whether the vehicle is eligible
for importation. The agency then
publishes this decision in the Federal
Register.
J.K. Technologies, LLC, of Baltimore,
Maryland (JK)(Registered Importer 90–
006) has petitioned NHTSA to decide
whether nonconforming 2006 and 2007
Subaru Forester passenger cars are
eligible for importation into the United
States. The vehicles which JK believes
are substantially similar are 2006 and
2007 Subaru Forester passenger cars
that were manufactured for sale in the
United States and certified by their
manufacturer as conforming to all
applicable FMVSS.
The petitioner claims that it compared
non-U.S. certified 2006 and 2007
Subaru Forester passenger cars to their
U.S.-certified counterparts, and found
the vehicles to be substantially similar
with respect to compliance with most
FMVSS.
JK submitted information with its
petition intended to demonstrate that
non-U.S. certified 2006 and 2007
Subaru Forester passenger cars, as
originally manufactured, conform to
many FMVSS in the same manner as
their U.S. certified counterparts, or are
capable of being readily altered to
conform to those standards.
Specifically, the petitioner claims that
non-U.S. certified 2006 and 2007
Subaru Forester passenger cars are
identical to their U.S. certified
counterparts with respect to compliance
with Standard Nos. 102 Transmission
Shift Lever Sequence, Starter Interlock,
and Transmission Braking Effect, 103
Windshield Defrosting and Defogging
Systems, 104 Windshield Wiping and
Washing Systems, 106 Brake Hoses, 109
New Pneumatic Tires, 113 Hood Latch
System, 116 Motor Vehicle Brake Fluids,
VerDate Aug<31>2005
15:33 Feb 29, 2008
Jkt 214001
124 Accelerator Control Systems, 135
Passenger Car Brake Systems, 201
Occupant Protection in Interior Impact,
202 Head Restraints, 204 Steering
Control Rearward Displacement, 205
Glazing Materials, 206 Door Locks and
Door Retention Components, 207
Seating Systems, 209 Seat Belt
Assemblies, 210 Seat Belt Assembly
Anchorages, 212 Windshield Mounting,
214 Side Impact Protection, 216 Roof
Crush Resistance, 219 Windshield Zone
Intrusion, 225 Child Restraint
Anchorage Systems, 301 Fuel System
Integrity, and 302 Flammability of
Interior Materials.
In addition, the petitioner claims that
the vehicles comply with the Bumper
Standard found in 49 CFR Part 581.
The petitioner also contends that the
vehicles are capable of being readily
altered to meet the following standards,
in the manner indicated:
Standard No. 101 Controls and
Displays: installation of a U.S.-model
instrument cluster that has been
reprogrammed to reflect the correct
mileage on the vehicle.
Standard No. 108 Lamps, Reflective
Devices and Associated Equipment: (a)
Installation of U.S.-model front
sidemarker lamps; (b) installation of
U.S.-model headlamps; and (c)
installation of U.S.-model taillamp
assemblies which incorporate rear U.S.model sidemarker lamps.
Standard no. 110 Tire Selection and
Rims: installation of vehicle placard.
Standard No. 111 Rearview Mirrors:
installation of a U.S.-model passenger
side rearview mirror, or inscription of
the required warning statement on the
face of that mirror.
Standard No. 114 Theft Protection:
installation of U.S. version software to
meet the requirements of this standard.
Standard No. 118 Power-Operated
Window, Partition, and Roof Panel
Systems: installation of U.S.-version
software to meet the requirements of
this standard.
Standard No. 208 Occupant Crash
Protection: (a) installation of U.S.version software to ensure that the seat
belt warning system meets the
requirements of this standard, and (b)
inspection of all vehicles and
replacement of any non-U.S.-model
components needed to achieve
conformity with this standard with U.S.model components.
The petitioner states that the
European version of the subject vehicle
does not meet the requirements of
FMVSS No. 208. According to the
petitioner, the passenger occupant
detection system must be added, the
driver’s and front passenger’s seat belt
buckle switch must be replaced, and the
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
11467
Control ECU must be reprogrammed.
The petitioner also states that on
account of regulatory differences around
the world parts of the occupant
protection system must be inspected to
verify that U.S.-model seat belts and
control units are installed.
The agency is especially interested in
obtaining comments concerning the
subject vehicle’s capability of being
readily altered to conform to the
advanced air bag requirements of this
standard. For example, the agency
wishes to know whether U.S.-model
components can be readily installed in
the subject vehicle and be readily
calibrated to interface with that vehicle
in such a way as to assure its conformity
with the air bag low risk deployment
and air bag automatic suppression
performance requirements of the
standard. The agency is willing to
consider all information relating to this
issue, be it test information or
otherwise.
The petitioner additionally states that
a vehicle identification plate must be
affixed to the vehicles near the left
windshield post to meet the
requirements of 49 CFR Part 565.
All comments received before the
close of business on the closing date
indicated above will be considered, and
will be available for examination in the
docket at the above addresses both
before and after that date. To the extent
possible, comments filed after the
closing date will also be considered.
Notice of final action on the petition
will be published in the Federal
Register pursuant to the authority
indicated below.
Authority: 49 U.S.C. 30141(a)(1)(A) and
(b)(1); 49 CFR 593.8; delegations of authority
at 49 CFR 1.50 and 501.8.
Issued on: February 26, 2008.
Claude H. Harris,
Director, Office of Vehicle Safety Compliance.
[FR Doc. E8–4026 Filed 2–29–08; 8:45 am]
BILLING CODE 4910–59–P
DEPARTMENT OF VETERANS
AFFAIRS
Genomic Medicine Program Advisory
Committee; Notice of Renewal
The Department of Veterans Affairs
(VA) gives notice that the Genomic
Medicine Program Advisory Committee
has been renewed for a two year period.
The Committee provides advice to the
Secretary of Veterans Affairs on the
scientific and ethical issues related to
the development and operation of VA’s
genomic medicine program. The
Committee is guided by the goal of
E:\FR\FM\03MRN1.SGM
03MRN1
11468
Federal Register / Vol. 73, No. 42 / Monday, March 3, 2008 / Notices
using genetic information to optimize
clinical care of veterans and to enhance
the study and development of
diagnostic tests and treatments for
diseases of particular relevance to
veterans.
Dated: February 22, 2008.
By Direction of the Secretary.
E. Philip Riggin,
Committee Management Officer.
[FR Doc. 08–910 Filed 2–29–08; 8:45 am]
BILLING CODE 8320–01–M
DEPARTMENT OF VETERANS
AFFAIRS
Advisory Committee on Minority
Veterans; Notice of Meeting
rmajette on PROD1PC64 with NOTICES
The Department of Veterans Affairs
(VA) gives notice under the Public Law
92–463 (Federal Advisory Committee
Act) that a meeting of the Advisory
Committee on Minority Veterans will be
held on March 31–April 3, 2008 at the
following locations: Fayetteville,
Salisbury, and Winston-Salem, North
Carolina. The sessions will be open to
the public.
The purpose of the Committee is to
advise the Secretary on the
administration of VA benefits and
services to minority veterans, to assess
the needs of minority veterans and to
evaluate whether VA compensation,
medical and rehabilitation services,
outreach, and other programs are
meeting those needs. The Committee
will make recommendations to the
Secretary regarding such activities.
VerDate Aug<31>2005
15:33 Feb 29, 2008
Jkt 214001
On March 31, 2008, the Committee
will meet from 9 a.m. to 4:15 p.m. at the
Fayetteville VA Medical Center
(VAMC), 2300 Ramsey Street,
Fayetteville, North Carolina. The
Committee will hold panel discussions
with key staff members from the VAMC
and with local Veterans Service
Organizations (VSOs) on services and
benefits delivery challenges, successes,
and concerns affecting Fayetteville area
veterans. Additionally, the Committee
will hold a town hall meeting at the
Holiday Inn I-95 located at 1944 Cedar
Creek Road in Fayetteville beginning at
6:30 p.m.
On April 1, 2008, the Committee will
meet from 9 am. to 12 noon at the
Womack Army Medical Center (AMC)
located in Building 4–2817 at Ft. Bragg
for a briefing from the Womack AMC
leadership, a tour of the facility, and to
visit with patients. Following this visit,
the Committee will depart for the
Lumbee Tribe of North Carolina to meet
with tribal representatives at 2709
Union Chapel Road, Pembroke, North
Carolina from 2:30 p.m. to 5:30 p.m.
On April 2, 2008, the Committee will
meet from 10:45 a.m. to 12:30 p.m. at
the Salisbury National Cemetery, 501
Statesville Blvd, Salisbury, North
Carolina for a tour and briefing. The
Committee will then depart at 12:45
p.m. for Winston-Salem, North Carolina.
The Committee will meet from 2 p.m. to
4 p.m. at the Winston-Salem VA
Regional Office at the Federal Building,
251 North Main Street, in WinstonSalem. The Committee will hold
discussions with key staff members
from the Winston-Salem VA Regional
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
Office on services and benefits, delivery
challenges, and successes. Additionally,
the Committee will hold a second town
hall meeting at the Winston-Salem
Marriott (460 N. Cherry Street)
beginning at 6:30 p.m. to hear comments
from the Winston-Salem area veterans.
The town hall meeting will adjourn at
8:30 p.m.
On April 3, 2008, the Committee will
meet from 10 a.m. to 5 p.m. at the
Holiday Inn I-95, Conference Room
Section III, 1944 Cedar Creek Road,
Fayetteville, North Carolina. The
Committee will conduct an exit briefing
with each of the VA teams involved in
the Committee’s activities on March 31–
April 2. The Committee will also work
on its annual report.
The Committee will accept written
comments from interested members of
the public on issues outlined in the
meeting agenda, as well as other issues
affecting minority veterans. Such
comments should be referred to the
Committee at the following address:
Advisory Committee on Minority
Veterans, Center for Minority Veterans
(00M), U.S. Department of Veterans
Affairs, 810 Vermont Avenue, NW.,
Washington, DC 20420.
For additional information about the
meeting, please contact Ms. Juanita
Mullen or Mr. Ronald Sagudan at (202)
461–6191.
Dated: February 27, 2008.
By Direction of the Secretary.
E. Philip Riggin,
Committee Management Officer.
[FR Doc. 08–922 Filed 2–29–08; 8:45 am]
BILLING CODE 8320–01–M
E:\FR\FM\03MRN1.SGM
03MRN1
Agencies
[Federal Register Volume 73, Number 42 (Monday, March 3, 2008)]
[Notices]
[Pages 11467-11468]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 08-910]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Genomic Medicine Program Advisory Committee; Notice of Renewal
The Department of Veterans Affairs (VA) gives notice that the
Genomic Medicine Program Advisory Committee has been renewed for a two
year period.
The Committee provides advice to the Secretary of Veterans Affairs
on the scientific and ethical issues related to the development and
operation of VA's genomic medicine program. The Committee is guided by
the goal of
[[Page 11468]]
using genetic information to optimize clinical care of veterans and to
enhance the study and development of diagnostic tests and treatments
for diseases of particular relevance to veterans.
Dated: February 22, 2008.
By Direction of the Secretary.
E. Philip Riggin,
Committee Management Officer.
[FR Doc. 08-910 Filed 2-29-08; 8:45 am]
BILLING CODE 8320-01-M